YOU SEARCHED BY...

MilliporeSigma

Remove all

SEARCH BY...

Contract Services Directory(1024)

Country

Contract Service Directory

MilliporeSigma

Company Headquarters

250 Frankfurter Straße,
Darmstadt, HE 64293
Germany

View Phone No.

Visit Website

Request More Info

Contract Service Directory

Content From MilliporeSigma

Videobite: Contract Pharma Sits Down with Josselyn Haas Durr of MilliporeSigma

Manufacturing Science and Technology Manager discusses M Lab Collaboration Centers and addressing customers pain points.

Videos Released on 12.20.2023
APIs | Bioanalytical Services | Biologics, Proteins, Vaccines

Build Quality into Biopharmaceutical Processes with Real-Time Monitoring and Control

The ability to monitor biopharma processes in real time provides significant advantages in optimizing product quality with respect to multiple attributes.

Sponsored Content Released on 12.13.2023
Biologics, Proteins, Vaccines | Process Development

Future-Proof Your Process with Modular Flexibility Today

MilliporeSigma unveils its new Mobius® iFlex Bioreactor family for fed-batch and perfusion upstream processes.

Sponsored Content Released on 09.07.2023
Bioanalytical Services | Information Technology

Bridging the Sponsor – CMO Data Gulf

How do sponsors and CMOs realize the advantages of their partnership while avoiding the pitfalls of clunky data sharing?

Sponsored Content Released on 06.06.2023
Excipients

Improve Process Economics & Enable High Protein Concentrations

This whitepaper spotlights how excipient combinations can enhance manufacturability and final concentration of mAb formulations.

White Papers / Tech Papers Released on 04.03.2023
Bioanalytical Services | Biologics, Proteins, Vaccines | cGMP Manufacture

Glucose Control in Cell Culture Using Raman

This automated approach minimizes the number of human interventions needed and reduces the risk of contamination and batch failures.

Sponsored Content Released on 03.21.2023
Filtration & Purification | Process Development | Validation

Enhancing Ease of Use, Batch Turnaround, and Process Flexibility

The Pellicon® Capsule is the first of its kind—a true single-use TFF device that streamlines bioprocessing with its innovative, simplified design.

Sponsored Content Released on 12.08.2022
Excipients | Formulation Development | Solid Dosage/Semi-solids

Enhancement of Tablet Coating Using an Innovative Functional Excipient

This white paper describes key considerations and provides guidance on the preparation of a coating formulation.

White Papers / Tech Papers Released on 08.30.2022
APIs

Explore the Next Generation Manufacturing of the Most Potent Compounds in Pharma

MilliporeSigma's new HPAPI contract manufacturing facility brings unmatched capacity to the market.

Sponsored Content Released on 06.09.2022
Drug Delivery | Excipients | Formulation Development

Overcoming Challenges in Ophthalmic Formulations Through Polymer Selection

This white paper provides an overview of polymers that can be used in ophthalmic formulations and highlights advantages offered using polyvinyl alcohol (PVA).

White Papers / Tech Papers Released on 06.02.2022
Biologics, Proteins, Vaccines | Drug Delivery | Excipients

Regulatory Considerations for Excipients Used in Lipid Nanoparticles

This whitepaper provides an overview on the regulatory classification and emerging regulatory challenges for LNP, liposomes, and novel excipients.

White Papers / Tech Papers Released on 06.01.2022
cGMP Manufacture | Scale-up/Technology Transfer

Challenges and Solutions in Viral Vector Manufacturing

The accelerated pathway through the clinic of viral vector-based cell and gene therapies puts pressure on developers to find a skilled partner.

Sponsored Content Released on 03.03.2022
Excipients

The Viscosity Reduction Platform: Viscosity-reducing excipients for protein formulation

This white paper evaluates the viscosity-reducing capacities of excipients and excipient combinations.

White Papers / Tech Papers Released on 01.20.2022
Biologics, Proteins, Vaccines | Process Development | Scale-up/Technology Transfer

Modification of Virus Spiking Procedures for Continuous Processes

This white paper demonstrates the feasibility of novel virus spiking strategies to meet the needs of continuous processes.

Sponsored Content Released on 12.10.2021

Login

Join

FOLLOW:

Subscribe Free

Magazine

eNewsletter

Checkout

YOU SEARCHED BY...

SEARCH BY...

Country

Contract Service Directory

MilliporeSigma

Company Headquarters

Contract Service Directory

Content From MilliporeSigma

Videobite: Contract Pharma Sits Down with Josselyn Haas Durr of MilliporeSigma

Build Quality into Biopharmaceutical Processes with Real-Time Monitoring and Control

Future-Proof Your Process with Modular Flexibility Today

Bridging the Sponsor – CMO Data Gulf

Improve Process Economics & Enable High Protein Concentrations

Glucose Control in Cell Culture Using Raman

Enhancing Ease of Use, Batch Turnaround, and Process Flexibility

Enhancement of Tablet Coating Using an Innovative Functional Excipient

Explore the Next Generation Manufacturing of the Most Potent Compounds in Pharma

Overcoming Challenges in Ophthalmic Formulations Through Polymer Selection

Regulatory Considerations for Excipients Used in Lipid Nanoparticles

Challenges and Solutions in Viral Vector Manufacturing

The Viscosity Reduction Platform: Viscosity-reducing excipients for protein formulation

Modification of Virus Spiking Procedures for Continuous Processes

follow us

Latest Breaking News From Nutraceuticals World

Latest Breaking News From Coatings World

Latest Breaking News From Medical Product Outsourcing

Latest Breaking News From Contract Pharma

Latest Breaking News From Beauty Packaging

Latest Breaking News From Happi

Latest Breaking News From Ink World

Latest Breaking News From Label & Narrow Web

Latest Breaking News From Nonwovens Industry

Latest Breaking News From Orthopedic Design & Technology

Latest Breaking News From Printed Electronics Now